Supplemental material
Human Vaccines & Immunotherapeutics
Volume 20, 2024 - Issue 1
Meningococcal
4CMenB journey to the 10-year anniversary and beyond
Véronique Abitbola GSK, Rueil-Malmaison, FranceCorrespondence[email protected]
https://orcid.org/0000-0003-0369-7715View further author information
https://orcid.org/0000-0003-0369-7715View further author information, Federico Martinón-Torresb Genetics, Vaccines and Infections Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago and Universidad de, Santiago de Compostela, Spain;c Translational Pediatrics and Infectious Diseases, Pediatrics Department, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain;d Consorcio Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spainhttps://orcid.org/0000-0002-9023-581XView further author information
https://orcid.org/0000-0002-9023-581XView further author information, Muhamed-Kheir Tahae Institut Pasteur, Université Paris Cité, Invasive Bacterial Infections Unit, National Reference Center for Meningococci and Haemophilus influenzae, Paris, Francehttps://orcid.org/0000-0002-0716-3174View further author information
https://orcid.org/0000-0002-0716-3174View further author information, Terry Nolanf Peter Doherty Institute for Infection & Immunity at University of Melbourne and Murdoch Children’s Research Institute, Melbourne, Australiahttps://orcid.org/0000-0001-6018-3863View further author information
https://orcid.org/0000-0001-6018-3863View further author information, Alessandro Muzzig GSK, Siena, Italyhttps://orcid.org/0000-0002-8635-6424View further author information
https://orcid.org/0000-0002-8635-6424View further author information, Stefania Bambinig GSK, Siena, Italyhttps://orcid.org/0009-0005-4115-9442View further author information
https://orcid.org/0009-0005-4115-9442View further author information, Ray Borrowh Meningococcal Reference Unit, UK Health Security Agency, Manchester, UKhttps://orcid.org/0000-0002-0691-6568View further author information
https://orcid.org/0000-0002-0691-6568View further author information, Daniela Toneattog GSK, Siena, Italyhttps://orcid.org/0000-0002-7661-4370View further author information
https://orcid.org/0000-0002-7661-4370View further author information, , Rino Rappuolig GSK, Siena, Italyhttps://orcid.org/0000-0002-8827-254XView further author information
https://orcid.org/0000-0002-8827-254XView further author information & Mariagrazia Pizzag GSK, Siena, Italyhttps://orcid.org/0000-0002-7800-1404View further author information
https://orcid.org/0000-0002-7800-1404View further author information show all